Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder
Running, not enrolling · Phase 2
Conditions studied: PTSD, Stress Disorders, Traumatic, Stress Disorders, Post-Traumatic, Trauma and Stressor Related Disorders, Mental Disorder
In brief
The primary aim of this study is to assess the safety and efficacy of psilocybin-assisted therapy in the treatment of post-traumatic stress disorder in United States military Veterans.
Key facts
- Study ID
- NCT05554094
- Run by
- Ohio State University
- People needed
- 15
- Starts
- 2023-01-01
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2026-03-04
Who can join
Age: 21 and older, up to 64. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Ohio State University Department of Psychiatry and Behavioral Health at the Davis Medical Research Center — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.